SynopsisThe global Medical Screen market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Medical Screen in various end use industries. The expanding demands from th.....
Synopsis Wound Protectors are currently used in surgery for wound retraction. They allow access to intra organs through an incision in surgery. Plastic wound retractors may also act as a barrier to bacterial translocation from the cavity to the wound.
Synopsis Computed axial tomography (CAT), popularly known as computed tomography (CT), has diversified applications in the healthcare industry. CT uses computer-processed X-ray images taken from different angles, and combines them to produce cross-sect.....
SynopsisChloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strai.....
SynopsisThe global Spinal Nerve Function Monitor market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while.....
SynopsisThe global Medical Infrared Thermography System market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considere.....
Synopsis The global Spinal Implant Surgical Instrument market size was valued at USD 15130 million in 2022 and is forecast to a readjusted size of USD 20450 million by 2029 with a CAGR of 4.4% during review period. The influence of COVID-19 and the Russi.....
SynopsisGlobal Straight Tube Stent Graft and Delivery System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Rus.....
Synopsis Velaglucerase alfa is a gene-activated human recombinant glucocerebrosidase used for the treatment of Type 1 Gaucher disease, caused by a deficiency of the lysosomal enzyme glucocerebrosidase. Additionally, Velaglucerase alfa has also been inves.....
SynopsisThe global Immunity Nutraceutical Ingredient market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immunity Nutraceutical Ingredient in various end use ind.....
